Literature DB >> 27155246

"Translational" medicine: transforming SPRINT findings into clinical practice.

Domenic A Sica1, Robert A Phillips2, William B White3, John D Bisognano4, Raymond R Townsend5.   

Abstract

Mesh：

Year:  2016        PMID： 27155246     DOI： 10.1016/j.jash.2016.03.192

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN： 1878-7436


× No keyword cloud information.
  3 in total

1.  Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).

Authors:  Adam P Bress; Holly Kramer; Rasha Khatib; Srinivasan Beddhu; Alfred K Cheung; Rachel Hess; Vinod K Bansal; Guichan Cao; Jerry Yee; Andrew E Moran; Ramon Durazo-Arvizu; Paul Muntner; Richard S Cooper
Journal:  Circulation       Date:  2017-02-13       Impact factor: 29.690

2.  Experts Provide a Glimpse of the New Post-SPRINT Era of Hypertension.

Authors:  Susan L Worley
Journal:  P T       Date:  2017-02

3.  Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults.

Authors:  Liping Chen; Yiyan Zhang; Juan Jin; Nannan Li; Dan Liu; Xinkun Zhai; Xiaodong Chen; Xiaodan Yuan
Journal:  Biomed Res Int       Date:  2020-10-17       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.